Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis

Figure 5

Forest plot of subgroup meta-analysis of the rates of disease progression at 6 months. (a) Subgroup analyses of intrathecal injection versus intravenous injection. (b) Subgroup analyses of baseline versus baseline . (c) Subgroup analyses of baseline versus baseline . (d) Subgroup analyses of MS versus MS . Squares indicate the risk ratio, and horizontal lines represent 95% confidence intervals.

(a)

(b)

(c)

(d)